Chervin-Petinot A, Courcon M, Almagro S, Nicolas A, Grichine A, Grunwald D, Prandini MH, Huber P and Gulino-Debrac D
Epithelial protein lost in neoplasm (EPLIN) interacts with α-catenin and actin filaments in endothelial cells and in vitro stabilizes the vascular capillary network.
Journal of Biological Chemistry, 2012, 287(10): 7556-7572
Publications
2012 
Un nouveau marqueur d’activité de la polyarthrite rhumatoïde : la VE-cadhérine circulante.
La Revue de Médecine Interne, 2012, 33(Supplement 1): S53
|
|
 |
Deroux A, Baudet A, Chiquet C, Altayrac J, Gallice M, Romanet JP, Gulino D, Vilgrain I and Bouillet L
Caractérisation d’anticorps anti-VE-cadhérine dans la choriorétinopathie de Birdshot.
La Revue de Médecine Interne, 2012, 33, Supplement 2(0): A67
Sidibe A, Mannic T, Arboleas M, Subileau M, Gulino-Debrac D, Bouillet L, Jan M, Vandhuick T, Le Loet X, Vittecoq O and Vilgrain I
Soluble VE-cadherin in rheumatoid arthritis patients correlates with disease activity: Evidence for tumor necrosis factor alpha-induced VE-cadherin cleavage.
Arthritis and Rheumatism, 2012, 64(1): 77-87
2011
Bouillet L, Mannic T, Arboleas M, Subileau M, Massot C, Drouet C, Huber P and Vilgrain I
Hereditary angioedema: Key role for kallikrein and bradykinin in vascular endothelial-cadherin cleavage and edema formation.
Journal of Allergy and Clinical Immunology, 2011, 128(1): 232-234
|
Chervin-Petinot A, Courcon M, Almagro S, Nicolas A, Grichine A, Grunwald D, Prandini MH, Huber P and Gulino-Debrac D |
|
2010
Almagro S, Durmort C, Chervin-Pétinot A, Heyraud S, Dubois M, Lambert O, Maillefaud C, Hewat E, Schaal JP, Huber P and Gulino-Debrac D
The motor protein Myosin-X transports VE-cadherin along filopodia to allow the formation of early endothelial cell-cell contacts.
Molecular and Cellular Biology, 2010, 30(7): 1703-1717
Gentil-Dit-Maurin A, Oun S, Almagro S, Bouillot S, Courcon M, Linnepe R, Vestweber D, Huber P and Tillet E
Unraveling the distinct distributions of VE- and N-cadherins in endothelial cells: A key role for p120-catenin.
Experimental Cell Research, 2010, 316(16): 2587-2599
2009
Heyraud S, Jaquinod M, Durmort C, Concord E, Schaal JP, Huber P and Gulino-Debrac D
Contribution of annexin II to the architecture of mature endothelial adherens junctions.
Molecular and Cellular Biology, 2008, 28(5): 1657-1668
Taveau JC, Dubois M, Le Bihan O, Trepout S, Almagro S, Hewat E, Durmort C, Heyraud S, Gulino-Debrac D and Lambert O
Structure of artificial and natural VE-cadherinbased adherens junctions.
Biochemical Society Transaction, 2008, 36(Pt 2): 189-193
2008
Bibert S, Ayari H, Riveline D, Concord E, Hermant B, Vernet T and Gulino-Debrac D
Establishment of cell-cell junctions depends on the oligomeric states of VE-cadherin.
Journal of Biochemistry, 2008, 143(6):821-832
Heyraud S, Jaquinod M, Durmort C, Concord E, Schaal JP, Huber P and Gulino-Debrac D
Contribution of annexin II to the architecture of mature endothelial adherens junctions.
Molecular and Cellular Biology, 2008, 28(5): 1657-1668
Taveau JC, Dubois M, Le Bihan O, Trépout S, Almagro S, Hewat E, Durmort C, Heyraud S, Gulino-Debrac D and Lambert O
Structure of artificial and natural VE-cadherin-based adherens junctions.
Biochemical Society Transaction, 2008, 36(Pt 2): 189-193
2007
Hewat EA, Durmort C, Jacquamet L, Concord E and Gulino-Debrac D
Architecture of the VE-cadherin hexamer.
Journal of Molecular Biology, 2007, 365(3): 744-751
Wallez Y, Cand F, Wernstedt C, Cruzalegui F, Souchelnytskyi S, Vilgrain I and Huber P
Src kinase phosphorylates vascular endothelial-cadherin in response to vascular endothelial growth factor: Identification of tyrosine 685 as the unique target site.
Oncogene, 2007, 26(7): 1067-107
2006
Wallez Y, Vilgrain I and Huber P
Angiogenesis: The VE-cadherin switch.
Trends in Cardiovascular Medicine, 2006, 16(2): 55-59
2005
Huber P, Mallet C, Faure E, Rampon C, Féraud O, Bouillot S and Vilgrain I
ACTH depletion represses VE-cadherin transcription in mouse adrenal endothelium in vivo.
Journal of Molecular Endocrinology, 2005, 34(1): 127-137
Hudry-Clergeon H, Stengel D, Ninio E and Vilgrain I
Platelet-activating factor increases VE-cadherin tyrosine phosphorylation in mouse endothelial cells and its association with the PtdIns3'-kinase.
Faseb Journal, 2005, 19(6): 512-520
Lambeng N, Wallez Y, Rampon C, Cand F, Christé G, Gulino Debrac D, Vilgrain I and Huber P
VE-cadherin tyrosine phosphorylation in angiogenic and quiescent adult tissues.
Circulation Research, 2005, 96(3): 384-391
2003
Feraud O, Mallet C and Vilgrain I
Expressional regulation of the angiopoietin-1 and -2 and the endothelial-specific receptor tyrosine kinase Tie2 in adrenal atrophy: A study of adrenocorticotropin-induced repair.
Endocrinology, 2003, 144(10): 4607-4615
Mallet C, Feraud O, Ouengue Mbele G, Gaillard I, Sappay N, Vittet D and Vilgrain I
Differential expression of VEGF receptors in adrenal atrophy induced by dexamethasone: A protective role of ACTH.
American Journal of Physiology - Endocrinology and Metabolism, 2003, 284(1): E156-67